Recipharm appoints Henrik Stenqvist as new Chief Financial Officer

11-Apr-2017 - Sweden

Recipharm AB today announced the appointment of Henrik Stenqvist as Recipharm’s new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. He will be based at the company’s headquarters in Stockholm, Sweden and reports to Thomas Eldered, Chief Executive Officer of Recipharm.

Henrik Stenqvist brings 24 years’ finance and management experience to Recipharm. Prior to joining Recipharm he served as CFO of the Meda Group and held other leading finance positions in the pharmaceutical industry. He holds a degree in Finance and Business Administration from the University of Linköping, Sweden.

Thomas Eldered says “I am very pleased to welcome Henrik, his extensive experience and perspectives in finance, business and strategic development in the pharmaceutical industry make him a great fit for Recipharm as we continue on our strong growth path.”

Henrik Stenqvist says "I'm looking forward to contributing to the continued success of Recipharm in my new capacity as Chief Financial Officer of this leading company."

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances